Life Sciences on the Rise: 2021 North American Report

Investment by Region Despite increasing interest by many geographies to expand the biotechnology industry in their areas, the industry remains significantly clustered in a few select areas with established histories in biotechnology and pharmaceuticals. Seventy-four percent of the $98 billion raised by life sciences companies in the five quarters ending with the first quarter of 2021 has been by ventures based in Boston, the San Francisco Bay Area, San Diego, New York City and New Jersey, with Boston-targeted investment accounting for 27% of the North American total. Despite the heavily clustered nature of the business, we do expect that public support, the increasing availability of biotechnology talent, and an increasing availability of capital will grow the industry in areas with currently scant drug discovery activity.

LIFE SCIENCES VC & PUBLIC CAPITAL INVESTED BY GIVEN REGION, 2020 THROUGH APRIL 2021: TOTAL RECTANGLE: $70 BILLION

Source: PitchBook

74% of the $98 billion raised by life sciences companies in the five quarters ending with the first quarter of 2021 has been by ventures based in Boston, the San Francisco Bay Area, San Diego, New York City and New Jersey

/ 9